A possible role for spontaneous interleukin‐8 production by acute myeloid leukemic cells in angiogenesis related processes: Work in progress
- 16 November 2001
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 37 (6) , 511-517
- https://doi.org/10.1002/mpo.1244
Abstract
Background Recently, the role of inter‐leukin‐8 (IL‐8) in angiogenesis was reported. We consequently addressed here the question whether IL‐8 produced by acute myeloid leukemia (AML) blasts might have a comparable function. Procedure In 21 pediatric patients with AML the role of AML derived IL‐8 in angiogenesis related processes were investigated. Therefore, IL‐8 protein and mRNA expression were measured and endothelial cell (EC) migration and proliferation assays were performed. In addition, bFGF and VEGF mRNA expression were measured by RT‐PCR. Results In the supernatant of the AML blasts, IL‐8 protein was present in a varying amount (median 0.86 μgL, range: 0.1–320 μg/L) and confirmed by RT–PCR. Normal bone marrow mononuclear cells secreted a significant lower amount of IL‐8 protein (median: 0.053 μg/L, range: 0.023–0.055 μg/L, P = 0.007).Seven of the 17 tested AML supernatants induced a varying low amount of EC proliferation compared to control media, which was not inhibited by anti‐IL‐8 antibodies. In contrast, in the EC migration assay, 15 out of the 17 AML supernatants tested, showed an increased EC migration (median fold increase: 1.97, range: 0.66–6.36, P = 0.002) compared to control medium. The increase in EC migration could partially be blocked by anti‐IL‐8 in 59% of the cases (18% decrease, range 0–62%, P = 0.003). Other contributors for the increase in EC migration were also determined. Vascular endothelial growth factor (VEGF) transcripts by RT‐PCR were demonstrated in six out of the nine tested AML cases, while no transcripts for basic fibroblast growth factor (VEGF) could be shown. Conclusions Neutralizing anti IL‐8 antibodies inhibit EC migration when stimulated with AML supernatant. This suggests a facilitating role for AML‐derived IL‐8 in an important step in angiogenesis. Med Pediatr Oncol 2001;37:511–517.Keywords
This publication has 22 references indexed in Scilit:
- Interleukin-8: an autocrine/paracrine growth factor for human hematopoietic progenitors acting in synergy with colony stimulating factor-1 to promote monocyte-macrophage growth and differentiationPublished by Elsevier ,1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Angiostatin induces and sustains dormancy of human primary tumors in miceNature Medicine, 1996
- lnterleukin-8 and Tumor Necrosis Factor-Alpha Are Involved in Human Aortic Endothelial Cell MigrationPathobiology, 1994
- Interleukin-8 as a Macrophage-Derived Mediator of AngiogenesisScience, 1992
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.Journal of Clinical Investigation, 1989
- Expression of the macrophage colony-stimulating factor and c-fms genes in human acute myeloblastic leukemia cells.Journal of Clinical Investigation, 1988
- Production of granulocyte colony-stimulating factor by acute myelomonocytic leukemia cellsLeukemia Research, 1988
- Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.Proceedings of the National Academy of Sciences, 1987
- Interleukin‐1 producing ability of leukaemia cells and its relationship to morphological diagnosisBritish Journal of Haematology, 1987